# Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6

> **NCT03341871** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 1095 (actual)

## Conditions studied

- Hepatitis C Virus (HCV)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03341871
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-27
- **Primary completion:** 2020-09-15
- **Final completion:** 2020-09-15
- **Target enrollment:** 1095 (ACTUAL)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341871, "Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03341871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*